Replies to post #6363 on Biostax Corp (BTAX)

[BuddyLou]

Bellicum Pharmaceuticals, Inc.$7.50

Celgene Corporation $76.50

Cellectis $28.00

Eureka (private company)

Juno Therapeutics (acquired by Celgenein 03/2018 9 billion)

Kite Pharma (acquired by Gilead for $11.9 billion)

Novartis AG (private company)

Sorrento Therapeutics $7.00

As LA pointed out, IMUN IS IN SOME GOOD COMPANY IN THIS REPORT!

Another thing to keep in mind is the price tag on the Juno and Kite buyouts. This is a good sign for both Cytocom/IMUN, if there are any future offers by the big players to acquire either. Cytocom being the main one, IMO, because of the U.S. patents, trials, research etc.